Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
PerkinElmer and Honeycomb Biotechnologies Launch the HIVE scRNAseq Solution for Single-Cell Analysis
Tuesday, October 19, 2021PerkinElmer Inc and Honeycomb Biotechnologies Inc announced today the commercial launch of the first of its kind HIVETM scRNAseq Solution for singlecell isolation and analysis The HIVE solution leverages a portable handheld device for the capture sto...
WuXi ATU Opens New Manufacturing Facility to Further Enhance Its CTDMO Services for Global Customers
Monday, October 18, 2021WuXi Advanced Therapies Inc a wholly owned subsidiary of WuXi AppTec today announced the opening of its new process development and commercial manufacturing facility in Lingang Shanghai WuXi ATU is a leading Contract Testing Development and Manufac...
Immusoft and Takeda Collaborate to Discover and Develop Cell Therapies for Rare Neurometabolic Disorders
Thursday, October 14, 2021Immusoft a cell therapy company dedicated to improving the lives of patients with rare diseases announced today that it has signed a research collaboration and license option agreement with Takeda Pharmaceutical Company Limited Takeda to discover dev...
Intellia Therapeutics and SparingVision Announce Strategic Collaboration to Develop Novel Ocular Therapies Using CRISPR/Cas9 Technology
Thursday, October 14, 2021Intellia Therapeutics Inc a leading clinicalstage genome editing company focused on developing curative therapeutics using CRISPRCas technology both in vivo and ex vivo and SparingVision a genomic medicine company developing vision saving treatments...
Sutro Biopharma and BioNova Pharmaceuticals Enter into Collaboration for STRO-001 in Greater China
Wednesday, October 13, 2021Sutro Biopharma Inc a clinicalstage drug discovery development and manufacturing company focused on the application of precise protein engineering and rational design to create nextgeneration cancer and autoimmune therapeutics and BioNova Pharmaceuti...
GeneCentric Therapeutics Collaborates with Labcorp to Develop Novel RNA-Based Oncology Diagnostics
Wednesday, October 13, 2021GeneCentric Therapeutics a company making precision medicine more precise through RNAbased diagnostics today announced a new strategic collaboration with Labcorp a leading global life sciences company to develop and commercialize new RNAbased gene si...
Sirtex Medical and China Grand Pharmaceutical announce successful first administration of SIR-Spheres® Y-90 resin microspheres in China
Tuesday, October 12, 2021Sirtex Medical a leading manufacturer of targeted liver cancer therapies announced today that the first procedure of selective internal radiation therapy SIRT using SIRSpheres Y resin microspheres in China was successfully performed for a patient wit...
Tegsedi® Receives Innovative Drug Category Pricing in Brazil
Tuesday, October 12, 2021PTC Therapeutics Inc announced that Tegsedi inotersen has successfully received Category classification from Cmara de Regulao do Mercado de Medicamentos CMED Drug Market Regulation Chamber in Brazil Category classification is given to innovative t...
BeiGene Announces BRUKINSA® (Zanubrutinib) Approved for Treatment of Patients with Mantle Cell Lymphoma
Monday, October 11, 2021BeiGene a global sciencedriven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide today announced that BRUKINSA zanubrutinib has been approved in Australia f...
Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio
Monday, October 11, 2021Supernus Pharmaceuticals Inc and Adamas Pharmaceuticals Inc today announced a definitive agreement for Supernus to acquire Adamas through a tender offer for per share in cash or an aggregate of approximately million payable at closing plus two nont...
